Study design
This study is a prospectively registered, parallel, two-armed, assessor-blinded, superiority randomized controlled trial. Three assessment points were performed (baseline, 8 weeks post-intervention, and 16 weeks follow-up) with probability sampling with randomization in an allocation ratio 1:1. The planned flow diagram of this trial is presented in Fig. Study design